ASST Spedali Civili di Brescia Awards €1.98M Single-Port Robotic System

Standfirst

ASST Spedali Civili di Brescia, one of Italy's largest hospital trusts, has awarded AB Medica SpA a framework agreement worth up to 30.76 million euros for the rental supply of a multi-specialist robotic surgical system using single-access technology, together with its related consumables, over an eight-year term. The tender attracted only one bidder, and the agreement includes a clause allowing another major Italian hospital to join later.

Introduction

Surgical robotics has moved from novelty to necessity in many of Europe's leading hospitals, and nowhere is that shift more visible than in the growing demand for single-access, or single-port, systems, platforms that let surgeons operate through a single small incision rather than the several ports traditional laparoscopic robotic surgery requires. Fewer incisions generally mean less trauma, faster recovery and reduced scarring for patients undergoing procedures across a range of specialties.

ASST Spedali Civili di Brescia, the public hospital trust serving Italy's Lombardy region from its base in Brescia, has just secured exactly this kind of technology through a long-term rental arrangement rather than an outright purchase, a structure increasingly common for hospitals seeking to keep pace with rapidly evolving robotic surgery platforms without locking themselves into owning equipment that may be superseded within a few years.

Why This Contract Matters

This is not a simple equipment purchase. It is a framework agreement running for 96 months, eight full years, structured as a rental arrangement covering both the robotic system itself and its ongoing consumable supplies, the disposable components single-access robotic surgery depends on for every procedure. Renting rather than buying gives the hospital trust flexibility to manage a rapidly advancing technology category without the capital risk of ownership, while still securing guaranteed access to the platform and its consumables for the better part of a decade.

The contract also carries a notable clause allowing IRCCS San Matteo di Pavia, another significant Italian research hospital, to subsequently adhere to the same agreement on the same terms, a structure that could see this single procurement exercise ultimately extend robotic surgical capability to a second major hospital without either institution needing to run its own separate competitive tender.

Contract Timeline

The winner was selected and the contract concluded on the same date, 10 September 2026. The notice recording this award was dispatched on 10 September 2026 and published in the Official Journal of the European Union on 14 September 2026, under OJ S issue 177/2026. The lot's service period runs from 1 January 2026 to 31 December 2033, an eight-year term that had already effectively begun before this specific award notice was formally published, with an option for a further twelve-month extension available beyond that.

Contract Overview

ASST Spedali Civili di Brescia ran an open procedure under Directive 2014/24/EU and Italy's national procurement code, Legislative Decree 36/2023, for a framework agreement covering the rental supply of specialist robotic systems and related consumables over a 96 month period. The classification is CPV code 33169500, Surgical tracking and tracing systems. The overall procedure, which appears to cover multiple lots beyond the one addressed in this notice, carries an estimated value and maximum framework value of 86,106,000.00 EUR excluding VAT.

This specific notice covers Lot 5, titled "Sistema robotico multispecialistico con tecnologia a singolo accesso", a multi-specialist robotic system using single-access technology. Its estimated value and maximum framework ceiling is 30,756,000.00 EUR excluding VAT. The buyer's own additional notes clarify that this estimated value is calculated to account for every possible contractual option set out in the tender documents, including the potential twelve-month extension and the subsequent adhesion clause for IRCCS San Matteo di Pavia, which is why the figure sits considerably higher than the base auction value used to actually run the competitive tender.

Only one tender was received for this lot. The winning bid, from AB Medica SpA, came in at 7,691,013.38 EUR, a figure dramatically lower than the 30.76 million euro ceiling, reflecting the difference between a framework's theoretical maximum value across every contractual scenario and the actual signed contract value reflecting realistic anticipated usage by Brescia's hospital trust alone.

Key Contract Details

Project Scope

The contract covers the rental supply, rather than outright purchase, of a multi-specialist robotic surgical system built around single-access technology, together with the related consumables the system requires to remain operational across the full eight-year term. Single-access, or single-port, robotic platforms are designed to allow complex minimally invasive procedures to be performed through one small incision rather than the multiple ports required by earlier generations of robotic and laparoscopic surgery, a distinction that matters clinically for patient recovery time, cosmetic outcome and infection risk.

The description "multispecialistico" indicates the system is intended to support procedures across several surgical specialties rather than being limited to a single clinical application, giving the hospital trust flexibility in how it deploys the technology across its surgical departments over the contract's long term.

About the Contracting Authority

ASST Spedali Civili di Brescia

ASST Spedali Civili di Brescia is registered as a body governed by public law with health as its classified activity, based in Brescia in Lombardy. It is one of Italy's largest hospital trusts, operating the Spedali Civili hospital complex, a major academic and clinical centre serving a substantial population across northern Italy. Its procurement decisions in advanced surgical technology carry weight both for its own clinical capability and, through mechanisms like the adhesion clause included in this contract, for other hospitals that may subsequently draw on the same agreement.

About the Organisations Involved

AB Medica SpA

AB Medica SpA, based in Cerro Maggiore in the Milan area, won this contract as the sole tenderer, with its bid formally ranked first and confirmed at 7,691,013.38 EUR. No subcontracting was declared, meaning AB Medica will deliver both the robotic system and its ongoing consumable supply directly over the contract's eight-year life. AB Medica is an established Italian medical technology company with a specific focus on advanced surgical and robotic systems, a niche segment of the broader medical device distribution market.

TAR Lombardia, Sezione di Brescia

The Tribunale Amministrativo Regionale della Lombardia, Brescia section, is named as the review organisation for this procurement, the standard body for hearing challenges to public procurement decisions in this part of Lombardy. Review deadline information in the notice simply refers bidders to the applicable statutory provisions rather than specifying a fixed number of days directly.

Procurement Analysis

This procurement was decided through a most economically advantageous tender methodology weighting quality at 70 points against price at just 30, a heavily technical evaluation that reflects how central clinical performance, safety and system capability are when a hospital is committing to a specific robotic surgery platform for the better part of a decade. In advanced surgical technology of this kind, the practical difference between competing systems, precision, range of compatible procedures, ergonomics for the surgical team and long term reliability, tends to matter far more to the buyer than marginal differences in rental price.

Only one tender was received for this lot, an outcome that is not unusual in the specialised market for single-access robotic surgical platforms, where the number of manufacturers capable of offering a genuinely multi-specialist system with this specific single-port capability remains relatively small globally. A single bidder scenario in this kind of technically demanding, clinically specific procurement often reflects genuine market concentration rather than any flaw in how the tender itself was structured or advertised.

The substantial gap between the lot's 30.76 million euro ceiling and the 7.69 million euro actual awarded value is worth understanding correctly rather than treating as any kind of inconsistency. The buyer's own additional notes explain this directly: the ceiling figure was deliberately calculated to cover every possible contractual scenario disclosed in the tender documents, including the potential twelve month extension option and, critically, the possibility that IRCCS San Matteo di Pavia exercises its right to adhere to the same contract later. The actual signed contract value reflects only Brescia's own anticipated usage as things currently stand, a much more modest, realistic figure. This is precisely the kind of framework agreement structure where readers should treat the ceiling as a theoretical maximum rather than assume the hospital trust is committing to spend anywhere near that amount.

Additional Procurement Facts

The contract is not financed with EU funds and is covered by the Government Procurement Agreement, meaning suppliers registered in GPA member countries outside the EU were also entitled to compete for this contract. No framework agreement reopening of competition mechanism applies, and no dynamic purchasing system is used. The procurement was run through Sintel, the Lombardy Region's telematic intermediation platform, with results published both on the hospital trust's own website and on the Sintel platform itself. Under article 120 of Italy's Legislative Decree 36/2023, the contract permits certain contractual modifications without requiring a new procurement procedure, regardless of the value involved, giving both parties some built in flexibility to adjust specific terms as the eight-year relationship progresses. Payment terms follow the operational instructions issued by ANAC, Italy's National Anti-Corruption Authority.

Market and Industry Perspective

Single-access robotic surgery represents one of the more technically advanced and commercially concentrated segments of the global medical device market, dominated by a handful of manufacturers capable of delivering platforms with genuine multi-specialty applicability through a single incision point. AB Medica's position as sole bidder for this specific lot reflects both its established relationship with Italian public hospitals in advanced surgical technology and the genuinely narrow field of credible competitors for this precise technical specification.

The rental structure adopted here, rather than outright capital purchase, also reflects a broader trend across European public hospital systems, where the pace of innovation in robotic surgery makes long term ownership commitments increasingly risky compared with rental or managed service arrangements that build in review points and extension options rather than locking a hospital into a single generation of technology for its full useful life.

Economic Significance

At an actual signed value of 7.69 million euros over eight years, this is a substantial, sustained investment in advanced surgical capability for Brescia's hospital trust, translating into a meaningful annual commitment once spread across the contract's full term. Should IRCCS San Matteo di Pavia exercise its adhesion right and join the agreement, the overall commercial scale of this contract for AB Medica could grow considerably closer to the lot's disclosed 30.76 million euro ceiling, though that outcome remains contingent rather than confirmed.

Future Procurement Opportunities

The subsequent adhesion clause built into this contract is the clearest near term development worth watching, since it could bring a second major Italian hospital, IRCCS San Matteo di Pavia, into the same agreement without any further competitive procurement process. The disclosed twelve month extension option is a further point to monitor as the contract's initial eight-year term approaches its 2033 conclusion.

Opportunities for Suppliers

Given the single bidder outcome and the specialised, technically demanding nature of single-access multi-specialty robotic surgery, direct competitive opportunity for other suppliers on this specific contract has now passed. However, manufacturers developing comparable single-port robotic platforms should watch closely for how this contract's adhesion mechanism and eventual renewal unfold, since Italian public hospital demand for this category of technology shows clear signs of expanding rather than contracting.

What Businesses Should Watch

Surgical robotics manufacturers and distributors should watch for whether IRCCS San Matteo di Pavia exercises its adhesion right under this contract, and should monitor how ASST Spedali Civili di Brescia's other lots within this same 86.1 million euro overall procedure are eventually resolved, since this notice covers only one part of a considerably larger multi-lot robotic surgery framework.

ItalyTenders.com Procurement Intelligence

This award offers a clear window into how Italian public hospitals are managing the genuinely rapid pace of change in surgical robotics, choosing long term rental commitments with built in flexibility rather than outright capital purchase, and structuring contracts with adhesion clauses that let other hospitals piggyback on a single competitive process rather than each running its own separate, resource intensive tender.

Its strategic importance lies in what the heavily quality weighted evaluation and single bidder outcome together reveal about this specific technology category. With quality carrying more than double the weight of price, and only one manufacturer coming forward with a qualifying bid, this segment of surgical robotics remains a genuinely specialised, concentrated market where clinical capability and proven reliability, not competitive pricing pressure, are what actually determine which supplier a major hospital trust chooses to work with for the better part of a decade.

Suppliers evaluating whether to enter this segment of the Italian public hospital market should recognise that success here depends less on undercutting an incumbent on price and more on developing genuinely differentiated single-access robotic technology capable of clearing the kind of rigorous, quality dominant evaluation processes Italian hospital trusts are now running for this category of equipment. The adhesion clause structure used in this specific contract is also worth studying closely, since it offers a template other Italian public hospital groups may increasingly adopt to extend the reach of a single successful procurement across multiple institutions without duplicating the administrative and clinical evaluation effort each time.

Supplier Takeaways

• Quality carried 70 of 100 available points, with price weighted at just 30, reflecting the clinical priority placed on proven surgical capability
• Only one tender was received, consistent with the genuinely narrow global field of manufacturers offering multi-specialty single-access robotic platforms
• The contract's 30.76 million euro ceiling reflects every possible contractual scenario, not the actual 7.69 million euro signed value
• A subsequent adhesion clause could extend this same contract to IRCCS San Matteo di Pavia without a further competitive tender
• The rental structure, rather than outright purchase, reflects a broader European hospital sector shift away from capital ownership of rapidly evolving robotic technology

Key Takeaways

• ASST Spedali Civili di Brescia has awarded AB Medica SpA a framework agreement for single-access robotic surgery, with a lot ceiling of 30,756,000.00 EUR and an actual signed value of 7,691,013.38 EUR
• The contract runs for 96 months, from January 2026 to December 2033, with a possible 12 month extension
• Only one tender was received for this lot, and the contract was concluded on 10 September 2026
• A subsequent adhesion clause allows IRCCS San Matteo di Pavia to potentially join the same agreement
• Award criteria weighted quality at 70 points against price at 30 points

Conclusion

This award gives Brescia's civil hospitals a long term route to advanced single-access robotic surgery capability, secured through a rental structure that balances clinical ambition against the practical risk of committing capital to a fast moving technology category. For AB Medica, it is a significant, multi year engagement that could grow further still if a second major Italian hospital chooses to join the same agreement. For Italy's broader surgical robotics market, this contract is a clear signal that quality and proven clinical capability, not price competition, remain the decisive factors in how the country's leading public hospitals choose their robotic surgery partners.

Source: Tenders Electronic Daily (TED), Contract Award Notice 630994 2026, Official Journal of the European Union, OJ S issue 177/2026, published on 14/09/2026.